Ask AI
ProCE Banner Series

The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients

Learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by difficult-to-treat pathogens such as Pseudomonas aeruginosa and Stenotrophomonas maltophilia.

All in-person learners must be registered for CHEST 2025 to attend in-person SS.

  ACPE
  | AMA
  | ANCC
Who Should Attend

This activity is intended for pulmonology, critical care, and infectious disease specialists, including physicians, nurses and clinical pharmacists, who care for critically ill patients with carbapenem-resistant gram-negative infections.

All Events

The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients

Upcoming Events

October

19

2025

12:00 PM - 1:15 PM Central Time (CT)

In-person

McCormick Place Convention Center, 2301 S. Martin Luther King Dr., Chicago, Illinois 60616

12:15 PM - 1:15 PM Central Time (CT)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Pneumonia.

Target Audience
This activity is intended for pulmonology, critical care, and infectious disease specialists, including physicians, nurses and clinical pharmacists, who care for critically ill patients with carbapenem-resistant gram-negative infections.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Reduce time to effective therapy in CRE infections involving diverse resistance mechanisms

  • Optimize antimicrobial regimens for complex infections involving Pseudomonas aeruginosa with difficult-to-treat resistance

  • Develop evidence-based antibiotic management plans for Stenotrophomonas maltophilia infections in critically ill patients

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-25-264-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.com to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC, in partnership with ProCE, LLC

Clinical Care Options, LLC

Supporters

Supported by an educational grant from Shionogi Pharma, Inc.

Shionogi Pharma, Inc.

Partners

ProCE, LLC

ProCE Banner

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191